Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFE2L1
|
ENSG00000082641.11 | nuclear factor, erythroid 2 like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_46126502_46126784 | NFE2L1 | 149 | 0.881288 | -0.81 | 8.4e-03 | Click! |
chr17_46127040_46127486 | NFE2L1 | 769 | 0.410027 | -0.64 | 6.4e-02 | Click! |
chr17_46129481_46129645 | NFE2L1 | 2127 | 0.154438 | -0.39 | 3.0e-01 | Click! |
chr17_46128188_46128339 | NFE2L1 | 1769 | 0.178230 | 0.34 | 3.7e-01 | Click! |
chr17_46129025_46129254 | NFE2L1 | 2551 | 0.133542 | -0.27 | 4.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_640639_641593 | 2.25 |
RAB40C |
RAB40C, member RAS oncogene family |
784 |
0.37 |
chr1_26610395_26611734 | 0.89 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
4451 |
0.13 |
chr3_141126707_141127060 | 0.82 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
5223 |
0.26 |
chr19_1168901_1169806 | 0.80 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
411 |
0.76 |
chr5_111304224_111304663 | 0.79 |
NREP-AS1 |
NREP antisense RNA 1 |
706 |
0.74 |
chr6_35393359_35394053 | 0.76 |
FANCE |
Fanconi anemia, complementation group E |
26432 |
0.15 |
chr16_88340108_88340439 | 0.75 |
ZNF469 |
zinc finger protein 469 |
153606 |
0.04 |
chr4_72242987_72243266 | 0.75 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
38356 |
0.23 |
chr2_36757574_36758239 | 0.71 |
RP11-78I14.1 |
|
17031 |
0.17 |
chr6_167034580_167034808 | 0.69 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
6031 |
0.28 |
chr5_52105602_52106304 | 0.67 |
CTD-2288O8.1 |
|
22093 |
0.18 |
chr4_77906953_77907316 | 0.67 |
SEPT11 |
septin 11 |
957 |
0.65 |
chr3_45589006_45589723 | 0.65 |
LARS2-AS1 |
LARS2 antisense RNA 1 |
38327 |
0.14 |
chr5_77843164_77843651 | 0.65 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
1567 |
0.55 |
chr9_128507884_128508777 | 0.65 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
1294 |
0.56 |
chr1_39916771_39917068 | 0.65 |
MACF1 |
microtubule-actin crosslinking factor 1 |
2590 |
0.26 |
chr1_162690967_162691118 | 0.64 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
45985 |
0.13 |
chr7_28667262_28667791 | 0.64 |
CREB5 |
cAMP responsive element binding protein 5 |
18848 |
0.29 |
chr5_71441214_71441365 | 0.63 |
ENSG00000264099 |
. |
24005 |
0.21 |
chr18_43168412_43168563 | 0.63 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
26279 |
0.19 |
chr2_19986384_19986783 | 0.62 |
TTC32 |
tetratricopeptide repeat domain 32 |
114819 |
0.06 |
chr6_144007887_144008177 | 0.62 |
PHACTR2 |
phosphatase and actin regulator 2 |
8827 |
0.27 |
chr14_53834899_53835050 | 0.61 |
RP11-547D23.1 |
|
214902 |
0.02 |
chr11_70261652_70262194 | 0.61 |
CTTN |
cortactin |
4308 |
0.17 |
chr1_66735904_66736482 | 0.61 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
12863 |
0.3 |
chr5_100760236_100760486 | 0.61 |
ENSG00000264318 |
. |
157173 |
0.04 |
chr10_103369371_103369522 | 0.61 |
ENSG00000263436 |
. |
8272 |
0.15 |
chr13_47149189_47149835 | 0.61 |
LRCH1 |
leucine-rich repeats and calponin homology (CH) domain containing 1 |
22117 |
0.25 |
chr8_21766211_21767399 | 0.60 |
DOK2 |
docking protein 2, 56kDa |
4369 |
0.22 |
chr1_109740426_109740857 | 0.60 |
ENSG00000238310 |
. |
9829 |
0.15 |
chr2_200138131_200138282 | 0.60 |
RP11-486F17.1 |
|
51827 |
0.17 |
chr15_89710472_89711584 | 0.60 |
RLBP1 |
retinaldehyde binding protein 1 |
44046 |
0.12 |
chr11_73024899_73025487 | 0.60 |
ARHGEF17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
2583 |
0.2 |
chr4_141177038_141177320 | 0.58 |
SCOC |
short coiled-coil protein |
1261 |
0.51 |
chr3_134396340_134396760 | 0.58 |
KY |
kyphoscoliosis peptidase |
26686 |
0.2 |
chr17_42872109_42872587 | 0.58 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
9986 |
0.14 |
chr21_40561834_40561985 | 0.58 |
AF129408.17 |
|
5514 |
0.18 |
chr4_120130830_120131163 | 0.57 |
RP11-455G16.1 |
Uncharacterized protein |
2671 |
0.26 |
chr7_139420465_139421101 | 0.57 |
HIPK2 |
homeodomain interacting protein kinase 2 |
1058 |
0.64 |
chr18_20945412_20945694 | 0.57 |
TMEM241 |
transmembrane protein 241 |
72264 |
0.09 |
chr8_126582644_126582795 | 0.57 |
ENSG00000266452 |
. |
125912 |
0.06 |
chr3_100621330_100621481 | 0.57 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
11903 |
0.26 |
chr3_114789964_114790115 | 0.57 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
183 |
0.98 |
chr5_106972962_106973113 | 0.57 |
EFNA5 |
ephrin-A5 |
33291 |
0.23 |
chr21_30706775_30707487 | 0.56 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
7534 |
0.17 |
chr1_78721233_78721384 | 0.56 |
ENSG00000237413 |
. |
26002 |
0.2 |
chr1_82172475_82172626 | 0.56 |
LPHN2 |
latrophilin 2 |
7095 |
0.3 |
chr4_187565964_187566324 | 0.56 |
FAT1 |
FAT atypical cadherin 1 |
46966 |
0.16 |
chr1_209780440_209781046 | 0.56 |
LAMB3 |
laminin, beta 3 |
11400 |
0.16 |
chr2_160890400_160890551 | 0.56 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
28646 |
0.23 |
chr15_99489885_99490412 | 0.56 |
IGF1R |
insulin-like growth factor 1 receptor |
22319 |
0.19 |
chr18_67715103_67715254 | 0.56 |
RTTN |
rotatin |
27224 |
0.24 |
chr5_149519603_149519837 | 0.55 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
2720 |
0.21 |
chr7_6056109_6056260 | 0.55 |
ENSG00000207217 |
. |
324 |
0.77 |
chr19_16961262_16961630 | 0.55 |
CTD-2538G9.5 |
|
6610 |
0.13 |
chr14_52519690_52519841 | 0.55 |
NID2 |
nidogen 2 (osteonidogen) |
14095 |
0.2 |
chr6_34351591_34352138 | 0.55 |
NUDT3 |
nudix (nucleoside diphosphate linked moiety X)-type motif 3 |
8587 |
0.19 |
chr2_40600387_40600603 | 0.54 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
56925 |
0.16 |
chr12_131357170_131358364 | 0.54 |
RAN |
RAN, member RAS oncogene family |
1126 |
0.44 |
chr18_415564_415715 | 0.54 |
RP11-720L2.2 |
|
8777 |
0.25 |
chr1_110922648_110923109 | 0.54 |
SLC16A4 |
solute carrier family 16, member 4 |
1073 |
0.36 |
chr2_128395165_128395808 | 0.54 |
LIMS2 |
LIM and senescent cell antigen-like domains 2 |
4220 |
0.16 |
chr7_24957612_24957858 | 0.54 |
OSBPL3 |
oxysterol binding protein-like 3 |
23 |
0.98 |
chr8_131350704_131350855 | 0.53 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
2404 |
0.44 |
chr13_75345669_75345820 | 0.53 |
ENSG00000206812 |
. |
337980 |
0.01 |
chr9_116318939_116319366 | 0.53 |
RGS3 |
regulator of G-protein signaling 3 |
8209 |
0.23 |
chr15_34153076_34153227 | 0.53 |
RP11-3D4.2 |
|
3875 |
0.25 |
chr4_77865038_77865189 | 0.53 |
SEPT11 |
septin 11 |
5743 |
0.25 |
chr9_79432035_79432186 | 0.53 |
PCA3 |
prostate cancer antigen 3 (non-protein coding) |
52758 |
0.16 |
chr18_46327589_46327944 | 0.53 |
RP11-484L8.1 |
|
33375 |
0.2 |
chr20_10629664_10629815 | 0.53 |
JAG1 |
jagged 1 |
13415 |
0.24 |
chr15_67399531_67400126 | 0.53 |
SMAD3 |
SMAD family member 3 |
8811 |
0.25 |
chr14_94432076_94432227 | 0.53 |
ASB2 |
ankyrin repeat and SOCS box containing 2 |
8278 |
0.16 |
chr16_87889321_87889990 | 0.53 |
SLC7A5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
7590 |
0.18 |
chr14_101308246_101309004 | 0.52 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr6_133873714_133873865 | 0.52 |
RP3-323P13.2 |
|
40923 |
0.19 |
chr9_18479738_18479998 | 0.52 |
ADAMTSL1 |
ADAMTS-like 1 |
5637 |
0.32 |
chr6_15206442_15206877 | 0.52 |
JARID2 |
jumonji, AT rich interactive domain 2 |
39868 |
0.15 |
chr2_47086635_47086786 | 0.52 |
AC016722.3 |
|
6075 |
0.17 |
chr6_2103859_2104525 | 0.52 |
GMDS |
GDP-mannose 4,6-dehydratase |
72033 |
0.13 |
chr7_104607714_104607865 | 0.52 |
ENSG00000251911 |
. |
3945 |
0.22 |
chr9_128640336_128640592 | 0.52 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
12914 |
0.3 |
chr8_69666100_69666251 | 0.52 |
ENSG00000239184 |
. |
58297 |
0.16 |
chr3_99989214_99989365 | 0.52 |
TBC1D23 |
TBC1 domain family, member 23 |
3253 |
0.26 |
chr1_249134690_249135278 | 0.52 |
ZNF672 |
zinc finger protein 672 |
1631 |
0.28 |
chr22_39378384_39379009 | 0.51 |
APOBEC3B |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
282 |
0.85 |
chr3_99036991_99037142 | 0.51 |
ENSG00000266030 |
. |
48667 |
0.19 |
chr15_42253361_42253691 | 0.51 |
EHD4 |
EH-domain containing 4 |
11250 |
0.12 |
chr14_23583246_23583696 | 0.51 |
CEBPE |
CCAAT/enhancer binding protein (C/EBP), epsilon |
5354 |
0.11 |
chr18_20273154_20273305 | 0.51 |
RP11-370A5.1 |
|
38299 |
0.17 |
chr9_124038362_124038896 | 0.51 |
RP11-477J21.6 |
|
6379 |
0.15 |
chr1_16466515_16466919 | 0.51 |
RP11-276H7.2 |
|
14989 |
0.11 |
chr10_89310955_89311253 | 0.51 |
ENSG00000222192 |
. |
11839 |
0.22 |
chr10_24735385_24735597 | 0.51 |
KIAA1217 |
KIAA1217 |
2871 |
0.34 |
chr11_10680453_10681322 | 0.50 |
MRVI1 |
murine retrovirus integration site 1 homolog |
6964 |
0.2 |
chr2_47025816_47026068 | 0.50 |
LINC01118 |
long intergenic non-protein coding RNA 1118 |
17880 |
0.16 |
chr9_130565627_130566870 | 0.50 |
FPGS |
folylpolyglutamate synthase |
645 |
0.49 |
chr5_71476037_71476188 | 0.50 |
MAP1B |
microtubule-associated protein 1B |
657 |
0.76 |
chr6_139724147_139724435 | 0.50 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
28534 |
0.23 |
chrX_134462748_134463038 | 0.50 |
ZNF75D |
zinc finger protein 75D |
15119 |
0.2 |
chr14_103045626_103045891 | 0.50 |
ENSG00000239224 |
. |
3756 |
0.21 |
chr7_114583964_114584237 | 0.50 |
MDFIC |
MyoD family inhibitor domain containing |
10176 |
0.32 |
chr5_14450759_14450910 | 0.50 |
TRIO |
trio Rho guanine nucleotide exchange factor |
37723 |
0.22 |
chr3_29228707_29228858 | 0.50 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
93691 |
0.09 |
chr6_17866546_17866697 | 0.50 |
KIF13A |
kinesin family member 13A |
49190 |
0.16 |
chr3_65932088_65932380 | 0.50 |
ENSG00000264716 |
. |
5312 |
0.21 |
chr5_131794846_131795957 | 0.49 |
ENSG00000202533 |
. |
8438 |
0.13 |
chr1_212702932_212703083 | 0.49 |
ATF3 |
activating transcription factor 3 |
35669 |
0.15 |
chr1_230849583_230849871 | 0.49 |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
316 |
0.87 |
chr9_72736818_72736969 | 0.49 |
MAMDC2-AS1 |
MAMDC2 antisense RNA 1 |
8117 |
0.25 |
chr8_97117053_97117204 | 0.49 |
GDF6 |
growth differentiation factor 6 |
55892 |
0.15 |
chr3_189721675_189721826 | 0.49 |
ENSG00000265045 |
. |
109973 |
0.06 |
chr19_10242764_10242915 | 0.49 |
EIF3G |
eukaryotic translation initiation factor 3, subunit G |
12261 |
0.08 |
chr9_16627752_16627903 | 0.49 |
RP11-62F24.1 |
|
2153 |
0.43 |
chr20_40260750_40261051 | 0.49 |
CHD6 |
chromodomain helicase DNA binding protein 6 |
13767 |
0.23 |
chr7_81255465_81255616 | 0.49 |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
136772 |
0.05 |
chr11_32055190_32055341 | 0.49 |
RP1-17K7.2 |
|
7529 |
0.17 |
chr1_76231815_76231966 | 0.49 |
RABGGTB |
Rab geranylgeranyltransferase, beta subunit |
19989 |
0.11 |
chr7_23019071_23019222 | 0.49 |
FAM126A |
family with sequence similarity 126, member A |
34547 |
0.2 |
chr17_44820432_44820772 | 0.48 |
NSF |
N-ethylmaleimide-sensitive factor |
16680 |
0.21 |
chr3_134184264_134184415 | 0.48 |
CEP63 |
centrosomal protein 63kDa |
20246 |
0.16 |
chr15_35832576_35832727 | 0.48 |
DPH6 |
diphthamine biosynthesis 6 |
5715 |
0.34 |
chr4_53886237_53886388 | 0.48 |
RP11-752D24.2 |
|
74456 |
0.11 |
chr9_4100181_4100332 | 0.48 |
RP11-70J12.1 |
|
28372 |
0.21 |
chr4_47527226_47527524 | 0.48 |
AC092597.3 |
|
34901 |
0.16 |
chr2_33467839_33468340 | 0.48 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
640 |
0.79 |
chr22_46083253_46083404 | 0.48 |
ATXN10 |
ataxin 10 |
15649 |
0.21 |
chr12_105621836_105621987 | 0.48 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
1727 |
0.42 |
chr14_33232996_33233147 | 0.48 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
28014 |
0.26 |
chr1_17559878_17560367 | 0.48 |
PADI1 |
peptidyl arginine deiminase, type I |
272 |
0.9 |
chr1_59594834_59594985 | 0.47 |
FGGY |
FGGY carbohydrate kinase domain containing |
167401 |
0.04 |
chr9_140681085_140681236 | 0.47 |
ENSG00000207693 |
. |
51711 |
0.13 |
chr11_130501333_130501484 | 0.47 |
C11orf44 |
chromosome 11 open reading frame 44 |
41443 |
0.21 |
chr11_88254615_88254766 | 0.47 |
GRM5-AS1 |
GRM5 antisense RNA 1 |
9774 |
0.3 |
chr8_18661932_18662083 | 0.47 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
332 |
0.91 |
chr16_47764879_47765030 | 0.47 |
PHKB |
phosphorylase kinase, beta |
34571 |
0.23 |
chr1_115870179_115870464 | 0.47 |
NGF |
nerve growth factor (beta polypeptide) |
10536 |
0.26 |
chr21_17444695_17444846 | 0.47 |
ENSG00000252273 |
. |
36941 |
0.23 |
chr12_93008867_93009018 | 0.47 |
ENSG00000238865 |
. |
70179 |
0.11 |
chr11_86527333_86527484 | 0.47 |
PRSS23 |
protease, serine, 23 |
15823 |
0.27 |
chr1_9268088_9268239 | 0.46 |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
26671 |
0.16 |
chr10_80916996_80917718 | 0.46 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
88565 |
0.09 |
chr15_89659888_89660039 | 0.46 |
ENSG00000239151 |
. |
4047 |
0.21 |
chr1_95257800_95258262 | 0.46 |
SLC44A3 |
solute carrier family 44, member 3 |
27867 |
0.18 |
chr2_19807324_19807591 | 0.46 |
OSR1 |
odd-skipped related transciption factor 1 |
249043 |
0.02 |
chr1_63578125_63578276 | 0.46 |
ENSG00000252259 |
. |
73921 |
0.12 |
chr8_121610510_121610731 | 0.46 |
MTBP |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa |
152954 |
0.04 |
chr1_42652119_42652270 | 0.46 |
FOXJ3 |
forkhead box J3 |
3286 |
0.26 |
chr22_37908037_37908429 | 0.46 |
CARD10 |
caspase recruitment domain family, member 10 |
15 |
0.97 |
chr18_51942431_51942582 | 0.46 |
C18orf54 |
chromosome 18 open reading frame 54 |
57551 |
0.14 |
chr10_49572050_49572337 | 0.46 |
MAPK8 |
mitogen-activated protein kinase 8 |
37493 |
0.18 |
chr3_120158350_120158501 | 0.46 |
FSTL1 |
follistatin-like 1 |
11413 |
0.25 |
chr17_39108643_39108794 | 0.46 |
KRT39 |
keratin 39 |
14426 |
0.08 |
chr9_5586517_5587285 | 0.46 |
KIAA1432 |
KIAA1432 |
42124 |
0.16 |
chr21_28311885_28312036 | 0.46 |
ENSG00000266133 |
. |
14320 |
0.21 |
chr12_11864478_11864709 | 0.45 |
ETV6 |
ets variant 6 |
40842 |
0.2 |
chr13_60321809_60321960 | 0.45 |
DIAPH3-AS1 |
DIAPH3 antisense RNA 1 |
265001 |
0.02 |
chr2_234119666_234119817 | 0.45 |
ATG16L1 |
autophagy related 16-like 1 (S. cerevisiae) |
1044 |
0.47 |
chr3_29734806_29734957 | 0.45 |
RBMS3-AS2 |
RBMS3 antisense RNA 2 |
50581 |
0.19 |
chr7_25162320_25162471 | 0.45 |
CYCS |
cytochrome c, somatic |
2473 |
0.37 |
chr5_64493902_64494516 | 0.45 |
ENSG00000207439 |
. |
75013 |
0.12 |
chr15_71335826_71335977 | 0.45 |
THSD4 |
thrombospondin, type I, domain containing 4 |
53390 |
0.14 |
chr4_122068382_122068533 | 0.45 |
TNIP3 |
TNFAIP3 interacting protein 3 |
5403 |
0.25 |
chr6_75893670_75893821 | 0.45 |
COL12A1 |
collagen, type XII, alpha 1 |
18763 |
0.23 |
chr7_132483257_132483408 | 0.45 |
AC009518.8 |
|
32121 |
0.17 |
chr4_119672667_119672818 | 0.45 |
SEC24D |
SEC24 family member D |
7055 |
0.28 |
chr1_206593311_206593758 | 0.45 |
SRGAP2 |
SLIT-ROBO Rho GTPase activating protein 2 |
13798 |
0.17 |
chr3_63997180_63997471 | 0.45 |
RP11-245J9.4 |
|
315 |
0.83 |
chr5_143397342_143397493 | 0.45 |
ENSG00000239390 |
. |
123027 |
0.06 |
chr3_10018102_10018700 | 0.45 |
EMC3 |
ER membrane protein complex subunit 3 |
9965 |
0.08 |
chrX_45571748_45571911 | 0.45 |
ENSG00000207870 |
. |
33865 |
0.2 |
chr2_179250736_179251021 | 0.45 |
AC009948.5 |
|
27788 |
0.15 |
chr8_132854804_132854955 | 0.45 |
EFR3A |
EFR3 homolog A (S. cerevisiae) |
61456 |
0.16 |
chr2_102733353_102733504 | 0.45 |
IL1R1 |
interleukin 1 receptor, type I |
12399 |
0.23 |
chr12_1552792_1552943 | 0.45 |
ERC1 |
ELKS/RAB6-interacting/CAST family member 1 |
35509 |
0.16 |
chr9_72837523_72837792 | 0.45 |
ENSG00000222465 |
. |
33991 |
0.14 |
chr10_29297172_29297323 | 0.45 |
ENSG00000199402 |
. |
133811 |
0.05 |
chr8_49466988_49467139 | 0.45 |
RP11-770E5.1 |
|
2936 |
0.41 |
chr17_48718114_48718630 | 0.44 |
ABCC3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
6154 |
0.13 |
chr4_55119045_55119196 | 0.44 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
9378 |
0.29 |
chr13_94962022_94962173 | 0.44 |
GPC6-AS1 |
GPC6 antisense RNA 1 |
121852 |
0.06 |
chr2_216395889_216396040 | 0.44 |
AC012462.1 |
|
94988 |
0.08 |
chr17_55950808_55951594 | 0.44 |
CUEDC1 |
CUE domain containing 1 |
1170 |
0.47 |
chr6_2477993_2478144 | 0.44 |
ENSG00000266252 |
. |
68199 |
0.13 |
chr14_69421781_69422763 | 0.44 |
ACTN1 |
actinin, alpha 1 |
8007 |
0.23 |
chr13_74792422_74792795 | 0.44 |
ENSG00000206617 |
. |
70743 |
0.12 |
chr2_75798574_75798725 | 0.44 |
EVA1A |
eva-1 homolog A (C. elegans) |
1801 |
0.32 |
chr15_36723081_36723232 | 0.44 |
C15orf41 |
chromosome 15 open reading frame 41 |
148656 |
0.05 |
chr3_11611925_11612156 | 0.44 |
VGLL4 |
vestigial like 4 (Drosophila) |
1642 |
0.43 |
chr8_69921640_69921791 | 0.44 |
ENSG00000238808 |
. |
101094 |
0.09 |
chr4_125337205_125337356 | 0.44 |
ANKRD50 |
ankyrin repeat domain 50 |
296607 |
0.01 |
chr20_58825387_58825538 | 0.44 |
ENSG00000207802 |
. |
58070 |
0.16 |
chr7_77826662_77826813 | 0.44 |
RP5-1185I7.1 |
|
207000 |
0.03 |
chr1_179061243_179061625 | 0.44 |
TOR3A |
torsin family 3, member A |
6927 |
0.23 |
chr5_135329366_135329517 | 0.44 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
35143 |
0.15 |
chr3_130755834_130755985 | 0.44 |
NEK11 |
NIMA-related kinase 11 |
7356 |
0.16 |
chr5_39501963_39502389 | 0.44 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
39774 |
0.22 |
chr2_47425913_47426195 | 0.43 |
CALM2 |
calmodulin 2 (phosphorylase kinase, delta) |
22314 |
0.19 |
chr12_14413818_14414239 | 0.43 |
ENSG00000251908 |
. |
10753 |
0.22 |
chr7_135375346_135375497 | 0.43 |
RP11-644N4.1 |
|
13864 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.8 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.3 | 1.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.5 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.7 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 | 0.9 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.9 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 1.2 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.4 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.2 | 1.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.6 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.7 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.2 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.3 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.2 | 1.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 3.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.6 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.2 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 1.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.1 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.3 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 1.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.7 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.3 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.1 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 1.5 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.7 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.8 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.1 | 0.3 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0072189 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter development(GO:0072189) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.4 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.7 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.3 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.4 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.2 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 1.2 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 1.1 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.0 | GO:0048668 | collateral sprouting(GO:0048668) |
0.0 | 0.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.4 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0051284 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.1 | GO:0042033 | chemokine biosynthetic process(GO:0042033) chemokine metabolic process(GO:0050755) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.0 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 0.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.2 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.9 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.5 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 4.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 7.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.6 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 10.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.7 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 2.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 1.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 1.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 2.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0046980 | tapasin binding(GO:0046980) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 6.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.5 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 3.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.6 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.9 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 4.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 1.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 2.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 1.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.0 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.0 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0022839 | calcium activated cation channel activity(GO:0005227) ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 6.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 10.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 5.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 7.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |